Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > HEALTHBEAT: Brain slows at 40, starts body decline (AP)

HEALTHBEAT: Brain slows at 40, starts body decline (AP)

AP - Think achy joints are the main reason we slow down as we get older? Blame the brain, too: The part in charge of motion may start a gradual downhill slide at age 40. How fast you can throw a ball or run or swerve a steering wheel depends on how speedily brain cells fire off commands to muscles. Fast firing depends on good insulation for your brain's wiring.

Click Here to read the entire article...

Other Articles:

•	PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements In Chloride Channel Function In Cystic Fibrosis Patients
	PTC Therapeutics, Inc. (PTC) announced that results from a randomized Phase 2a European study demonstrated that treatment with the investigational drug PTC124 caused statistically significant improvements in the chloride channel function of children with cystic fibrosis (CF) caused by a particular genetic mutation, called a nonsense mutation. Results from the study were presented today by Isabelle SermetGaudelus, M.D., Ph.D.
	Click Here to read the entire article...

•	Listen to The Lancet: 20 September
	Professor Richard Beasley discusses in a podcast results of the ISAAC-3 study, suggesting a strong association between paracetamol use in infancy and increased risk of asthma by age 6-7 years.
	Click Here to read the entire article...

•	Fireworks
	none
	Click Here to read the entire article...

•

	Click Here to read the entire article...

•	Medtech Startups, December 2007
	New medical technologies represented in companies added (December 2007) to the Medtech Startups Database and/or added to the December 2007 issue of MedMarkets. The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of December: EEG analysis for applications such as detection and prediction of seizure. Drugs targeting inflammatory and metabolic pathways, including obesity, type 2 diabetes and cardiovascular disease. In vivo transdifferentiation to regenerate ischemic or diseased organs. Developing small molecule drugs to reprogram adult stem cells. Orthopedic devices for pediatric and other small stature patients. Devices and apparatus for insertion of flexible implants (e.g. breast implants, others). Implantable devices; e.g., to prevent cerebrospinal fluid leaks. Minimally invasive spinal instrumentation. Intra-operative 3D imaging for earlier diagnosis of breast cancer. Now Published!: Worldwide Wound Management 2007-2016. see link For coverage in specific issues of MedMarkets, see link. For details on the Medtech Startups Database, see link. Tags: medtech, startup
	Click Here to read the entire article...

•	[Biophysics] Multiple receptors involved in human rhinovirus attachment to live cells
	Minor group human rhinoviruses (HRVs) attach to members of the low-density lipoprotein receptor family and are internalized via receptor-mediated endocytosis....
	Click Here to read the entire article...